Just for my own peace of mind can we confirm factually that our cells are good for a treatment in covid ards .I'm hearing (from the knockers ) that as a treatment they may be to expensive and required to be given before the symptoms are to bad, which a lot of people receiving them may not need . Then they are not effective on over 65's which are the main group for death and ventilation .If this is correct are we expecting to much for the cells as a preferred treatment of covid ards when the standard of care has seen a big reduction in deaths from covid ards and now the majority of deaths are over 65's .There are also a number of treatments coming out . I know non covid ards is a still a big market . Can any one give thoughts on the above as a discussion i'd just like some clarity ..
- Forums
- ASX - By Stock
- MSB
- $90 a share on COVID ARDS Authorization ?
$90 a share on COVID ARDS Authorization ?, page-228
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B |
Open | High | Low | Value | Volume |
$1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 43856 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.11 | 66000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 43856 | 1.105 |
10 | 148573 | 1.100 |
3 | 95461 | 1.095 |
6 | 150805 | 1.090 |
4 | 77833 | 1.085 |
Price($) | Vol. | No. |
---|---|---|
1.110 | 66000 | 1 |
1.115 | 89808 | 3 |
1.120 | 510896 | 9 |
1.125 | 100845 | 7 |
1.130 | 142733 | 8 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |